Maternal taurine supplementation attenuates maternal fructose-induced metabolic and inflammatory dysregulation and partially reverses adverse metabolic programming in offspring

Journal of Nutritional Biochemistry

Volumn 26, Issue 3, 2015, Pages 267-276

  Li, M ^a   Reynolds, C M ^a   Sloboda, D M ^a,b   Gray, C ^a   Vickers, M H ^a  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

^b MCMASTER UNIVERSITY   (Canada)

Author keywords

Animal models; Developmental programming; Fatty liver disease; Fructose; Inflammation; Maternal nutrition; Taurine

Indexed keywords

CHOLESTEROL; CYTOKINE; DRINKING WATER; FATTY ACID; FATTY ACID SYNTHASE; FRUCTOSE; GLUCOSE; HOMOCYSTEINE; HYPOXANTHINE PHOSPHORIBOSYLTRANSFERASE; INSULIN; INTERLEUKIN 1BETA; INTERLEUKIN 6; LEPTIN; PHOSPHOENOLPYRUVATE CARBOXYKINASE (GTP); STEROL REGULATORY ELEMENT BINDING PROTEIN 1C; TAURINE; TRIACYLGLYCEROL; TRIACYLGLYCEROL LIPASE; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR 1; SREBF1 PROTEIN, RAT; STEROL REGULATORY ELEMENT BINDING PROTEIN 1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ATTENUATION; BIRTH WEIGHT; CALORIC INTAKE; CONTROLLED STUDY; DIET SUPPLEMENTATION; FATTY LIVER; FEMALE; GENE EXPRESSION; HOMEOSTASIS; HYPERINSULINEMIA; INFLAMMATION; LACTATION; LIVER WEIGHT; MALE; METABOLIC DISORDER; NEWBORN; NEWBORN DEATH; NONHUMAN; PREGNANCY; PROGENY; RAT; AGONISTS; ANIMAL; ANTAGONISTS AND INHIBITORS; BLOOD; CHEMISTRY; DIETARY SUPPLEMENT; ENZYMOLOGY; FETUS DEVELOPMENT; GENE EXPRESSION REGULATION; GENETICS; INSULIN RESISTANCE; LIVER; MATERNAL NUTRITION; METABOLIC SYNDROME X; METABOLISM; NON-ALCOHOLIC FATTY LIVER DISEASE; ORGAN SIZE; PATHOLOGY; PATHOPHYSIOLOGY; RANDOMIZATION; SEXUAL DEVELOPMENT; WISTAR RAT;

ANIMALIA; RATTUS; RATTUS NORVEGICUS;

ANIMALS; CYTOKINES; DIETARY SUPPLEMENTS; FATTY ACID SYNTHASES; FEMALE; FETAL DEVELOPMENT; FRUCTOSE; GENE EXPRESSION REGULATION, DEVELOPMENTAL; INSULIN RESISTANCE; LACTATION; LIVER; MALE; MATERNAL NUTRITIONAL PHYSIOLOGICAL PHENOMENA; METABOLIC SYNDROME X; NON-ALCOHOLIC FATTY LIVER DISEASE; ORGAN SIZE; PREGNANCY; RANDOM ALLOCATION; RATS, WISTAR; SEX CHARACTERISTICS; STEROL REGULATORY ELEMENT BINDING PROTEIN 1; TAURINE;

EID: 84927690232     PISSN: 09552863     EISSN: 18734847     Source Type: Journal    
DOI: 10.1016/j.jnutbio.2014.10.015     Document Type: Article

References (59)

1. Hanover L.M., White J.S. Manufacturing, composition, and applications of fructose. Am J Clin Nutr 1993, 58:724S-732S.
2. Johnson R.J., Nakagawa T., Sanchez-Lozada L.G., Shafiu M., Sundaram S., Le M., et al. Sugar, uric acid, and the etiology of diabetes and obesity. Diabetes 2013, 62:3307-3315.
3. Bray G.A., Nielsen S.J., Popkin B.M. Consumption of high-fructose corn syrup in beverages may play a role in the epidemic of obesity. Am J Clin Nutr 2004, 79:537-543.
4. Stanhope K.L., Schwarz J.M., Keim N.L., Griffen S.C., Bremer A.A., Graham J.L., et al. Consuming fructose-sweetened, not glucose-sweetened, beverages increases visceral adiposity and lipids and decreases insulin sensitivity in overweight/obese humans. J Clin Invest 2009, 119:1322-1334.
5. Perez-Pozo S.E., Schold J., Nakagawa T., Sanchez-Lozada L.G., Johnson R.J., Lillo J.L. Excessive fructose intake induces the features of metabolic syndrome in healthy adult men: role of uric acid in the hypertensive response. Int J Obes (Lond) 2010, 34:454-461.
6. Ackerman Z., Oron-Herman M., Grozovski M., Rosenthal T., Pappo O., Link G., et al. Fructose-induced fatty liver disease: hepatic effects of blood pressure and plasma triglyceride reduction. Hypertension 2005, 45:1012-1018.
7. Hwang I.S., Ho H., Hoffman B.B., Reaven G.M. Fructose-induced insulin resistance and hypertension in rats. Hypertension 1987, 10:512-516.
8. Vickers M.H., Clayton Z.E., Yap C., Sloboda D.M. Maternal fructose intake during pregnancy and lactation alters placental growth and leads to sex-specific changes in fetal and neonatal endocrine function. Endocrinology 2011, 152:1378-1387.
9. Zou M., Arentson E.J., Teegarden D., Koser S.L., Onyskow L., Donkin S.S. Fructose consumption during pregnancy and lactation induces fatty liver and glucose intolerance in rats. Nutr Res 2012, 32:588-598.
10. Mukai Y., Kumazawa M., Sato S. Fructose intake during pregnancy up-regulates the expression of maternal and fetal hepatic sterol regulatory element-binding protein-1c in rats. Endocrine 2013, 44:79-86.
11. Fetita L.S., Sobngwi E., Serradas P., Calvo F., Gautier J.F. Consequences of fetal exposure to maternal diabetes in offspring. J Clin Endocrinol Metab 2006, 91:3718-3724.
12. Silverman B.L., Metzger B.E., Cho N.H., Loeb C.A. Impaired glucose tolerance in adolescent offspring of diabetic mothers. Relationship to fetal hyperinsulinism. Diabetes Care 1995, 18:611-617.
13. Gluckman P.D., Hanson M.A., Beedle A.S. Early life events and their consequences for later disease: a life history and evolutionary perspective. Am J Hum Biol 2007, 19:1-19.
14. Rodriguez L., Panadero M.I., Roglans N., Otero P., Alvarez-Millan J.J., Laguna J.C., et al. Fructose during pregnancy affects maternal and fetal leptin signaling. J Nutr Biochem 2013, 24:1709-1716.
15. Worden J.A., Stipanuk M.H. A comparison by species, age and sex of cysteinesulfinate decarboxylase activity and taurine concentration in liver and brain of animals. Comp Biochem Physiol B 1985, 82:233-239.
16. Carneiro E.M., Latorraca M.Q., Araujo E., Beltra M., Oliveras M.J., Navarro M., et al. Taurine supplementation modulates glucose homeostasis and islet function. J Nutr Biochem 2009, 20:503-511.
17. Nakaya Y., Minami A., Harada N., Sakamoto S., Niwa Y., Ohnaka M. Taurine improves insulin sensitivity in the Otsuka Long-Evans Tokushima Fatty rat, a model of spontaneous type 2 diabetes. Am J Clin Nutr 2000, 71:54-58.
18. Anuradha C.V., Balakrishnan S.D. Taurine attenuates hypertension and improves insulin sensitivity in the fructose-fed rat, an animal model of insulin resistance. Can J Physiol Pharmacol 1999, 77:749-754.
19. Gentile C.L., Nivala A.M., Gonzales J.C., Pfaffenbach K.T., Wang D., Wei Y., et al. Experimental evidence for therapeutic potential of taurine in the treatment of nonalcoholic fatty liver disease. Am J Physiol Regul Integr Comp Physiol 2011, 301:R1710-R1722.
20. Cherif H., Reusens B., Ahn M.T., Hoet J.J., Remacle C. Effects of taurine on the insulin secretion of rat fetal islets from dams fed a low-protein diet. J Endocrinol 1998, 159:341-348.
21. Boujendar S., Reusens B., Merezak S., Ahn M.T., Arany E., Hill D., et al. Taurine supplementation to a low protein diet during foetal and early postnatal life restores a normal proliferation and apoptosis of rat pancreatic islets. Diabetologia 2002, 45:856-866.
22. Merezak S., Reusens B., Renard A., Goosse K., Kalbe L., Ahn M.T., et al. Effect of maternal low-protein diet and taurine on the vulnerability of adult Wistar rat islets to cytokines. Diabetologia 2004, 47:669-675.
23. Tang C., Marchand K., Lam L., Lux-Lantos V., Thyssen S.M., Guo J., et al. Maternal taurine supplementation in rats partially prevents the adverse effects of early-life protein deprivation on beta-cell function and insulin sensitivity. Reproduction 2013, 145:609-620.
24. Li M., Reynolds C.M., Sloboda D.M., Gray C., Vickers M.H. Effects of taurine supplementation on hepatic markers of inflammation and lipid metabolism in mothers and offspring in the setting of maternal obesity. PLoS One 2013, 8:e76961.
25. Matthews D.R., Hosker J.P., Rudenski A.S., Naylor B.A., Treacher D.F., Turner R.C. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985, 28:412-419.
26. Livak K.J., Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001, 25:402-408.
27. Shanik M.H., Xu Y., Skrha J., Dankner R., Zick Y., Roth J. Insulin resistance and hyperinsulinemia: is hyperinsulinemia the cart or the horse?. Diabetes Care 2008, 31(Suppl. 2):S262-S268.
28. Miller A., Adeli K. Dietary fructose and the metabolic syndrome. Curr Opin Gastroenterol 2008, 24:204-209.
29. Hauth J.C., Clifton R.G., Roberts J.M., Myatt L., Spong C.Y., Leveno K.J., et al. Maternal insulin resistance and preeclampsia. Am J Obstet Gynecol 2011, 204:327.e1-327.e6.
30. Catalano P.M. Obesity, insulin resistance, and pregnancy outcome. Reproduction 2010, 140:365-371.
31. Williams D. Long-term complications of preeclampsia. Semin Nephrol 2011, 31:111-122.
32. Metzger B.E. Long-term outcomes in mothers diagnosed with gestational diabetes mellitus and their offspring. Clin Obstet Gynecol 2007, 50:972-979.
33. Kim K.S., Oh da H., Kim J.Y., Lee B.G., You J.S., Chang K.J., et al. Taurine ameliorates hyperglycemia and dyslipidemia by reducing insulin resistance and leptin level in Otsuka Long-Evans Tokushima fatty (OLETF) rats with long-term diabetes. Exp Mol Med 2012, 44:665-673.
34. El Mesallamy H.O., El-Demerdash E., Hammad L.N., El Magdoub H.M. Effect of taurine supplementation on hyperhomocysteinemia and markers of oxidative stress in high fructose diet induced insulin resistance. Diabetol Metab Syndr 2010, 2:46.
35. Ribeiro R.A., Vanzela E.C., Oliveira C.A., Bonfleur M.L., Boschero A.C., Carneiro E.M. Taurine supplementation: involvement of cholinergic/phospholipase C and protein kinase A pathways in potentiation of insulin secretion and Ca2+ handling in mouse pancreatic islets. Br J Nutr 2010, 104:1148-1155.
36. Mathis D., Shoelson S.E. Immunometabolism: an emerging frontier. Nat Rev Immunol 2011, 11:81.
37. Kern P.A., Ranganathan S., Li C., Wood L., Ranganathan G. Adipose tissue tumor necrosis factor and interleukin-6 expression in human obesity and insulin resistance. Am J Physiol Endocrinol Metab 2001, 280:E745-E751.
38. McGillicuddy F.C., Harford K.A., Reynolds C.M., Oliver E., Claessens M., Mills K.H., et al. Lack of interleukin-1 receptor I (IL-1RI) protects mice from high-fat diet-induced adipose tissue inflammation coincident with improved glucose homeostasis. Diabetes 2011, 60:1688-1698.
39. Hotamisligil G.S., Murray D.L., Choy L.N., Spiegelman B.M. Tumor necrosis factor alpha inhibits signaling from the insulin receptor. Proc Natl Acad Sci U S A 1994, 91:4854-4858.
40. Schuller-Levis G.B., Park E. Taurine: new implications for an old amino acid. FEMS Microbiol Lett 2003, 226:195-202.
41. Park E., Jia J., Quinn M.R., Schuller-Levis G. Taurine chloramine inhibits lymphocyte proliferation and decreases cytokine production in activated human leukocytes. Clin Immunol 2002, 102:179-184.
42. Marcinkiewicz J., Grabowska A., Bereta J., Stelmaszynska T. Taurine chloramine, a product of activated neutrophils, inhibits in vitro the generation of nitric oxide and other macrophage inflammatory mediators. J Leukoc Biol 1995, 58:667-674.
43. Joo K., Lee Y., Choi D., Han J., Hong S., Kim Y.M., et al. An anti-inflammatory mechanism of taurine conjugated 5-aminosalicylic acid against experimental colitis: taurine chloramine potentiates inhibitory effect of 5-aminosalicylic acid on IL-1beta-mediated NFkappaB activation. Eur J Pharmacol 2009, 618:91-97.
44. Postic C., Girard J. The role of the lipogenic pathway in the development of hepatic steatosis. Diabetes Metab 2008, 34:643-648.
45. Havel P.J. Dietary fructose: implications for dysregulation of energy homeostasis and lipid/carbohydrate metabolism. Nutr Rev 2005, 63:133-157.
46. Ouyang X., Cirillo P., Sautin Y., McCall S., Bruchette J.L., Diehl A.M., et al. Fructose consumption as a risk factor for non-alcoholic fatty liver disease. J Hepatol 2008, 48:993-999.
47. Stoeckman A.K., Towle H.C. The role of SREBP-1c in nutritional regulation of lipogenic enzyme gene expression. J Biol Chem 2002, 277:27029-27035.
48. Goldberg I.J., Eckel R.H., Abumrad N.A. Regulation of fatty acid uptake into tissues: lipoprotein lipase- and CD36-mediated pathways. J Lipid Res 2009, 50:S86-S90.
49. Schoonjans K., Staels B., Auwerx J. The peroxisome proliferator activated receptors (PPARS) and their effects on lipid metabolism and adipocyte differentiation. Biochim Biophys Acta 1996, 1302:93-109.
50. Foretz M., Pacot C., Dugail I., Lemarchand P., Guichard C., Le Liepvre X., et al. ADD1/SREBP-1c is required in the activation of hepatic lipogenic gene expression by glucose. Mol Cell Biol 1999, 19:3760-3768.
51. Vickers M.H., Gluckman P.D., Coveny A.H., Hofman P.L., Cutfield W.S., Gertler A., et al. Neonatal leptin treatment reverses developmental programming. Endocrinology 2005, 146:4211-4216.
52. Gray C., Li M., Reynolds C.M., Vickers M.H. Pre-weaning growth hormone treatment reverses hypertension and endothelial dysfunction in adult male offspring of mothers undernourished during pregnancy. PLoS One 2013, 8:e53505.
53. Reynolds C.M., Li M., Gray C., Vickers M.H. Pre-weaning growth hormone treatment ameliorates bone marrow macrophage inflammation in adult male rat offspring following maternal undernutrition. PLoS One 2013, 8:e68262.
54. Holness M.J., Langdown M.L., Sugden M.C. Early-life programming of susceptibility to dysregulation of glucose metabolism and the development of Type 2 diabetes mellitus. Biochem J 2000, 349(Pt 3):657-665.
55. Martin-Gronert M.S., Ozanne S.E. Metabolic programming of insulin action and secretion. Diabetes Obes Metab 2012, 14(Suppl. 3):29-39.
56. Kamari Y., Shaish A., Vax E., Shemesh S., Kandel-Kfir M., Arbel Y., et al. Lack of interleukin-1alpha or interleukin-1beta inhibits transformation of steatosis to steatohepatitis and liver fibrosis in hypercholesterolemic mice. J Hepatol 2011, 55:1086-1094.
57. Gray C., Long S., Green C., Gardiner S.M., Craigon J., Gardner D.S. Maternal fructose and/or salt intake and reproductive outcome in the rat: effects on growth, fertility, sex ratio, and birth order. Biol Reprod 2013, 89:51.
58. Williamson D.H., Thornton P.S. Ketone body production and metabolism in the fetus and neonate. Fetal and neonatal physiology 2011, 487-495. Elsevier/Saunders, Philadelphia. 4th ed. R.A. Polin, W.W. Fox, S.H. Abman (Eds.).
59. Laffel L. Ketone bodies: a review of physiology, pathophysiology and application of monitoring to diabetes. Diabetes Metab Res Rev 1999, 15:412-426.